NasdaqGS - Nasdaq Real Time Price USD

Mineralys Therapeutics, Inc. (MLYS)

14.65
-0.96
(-6.15%)
At close: May 9 at 4:00:00 PM EDT
14.65
0.00
(0.00%)
After hours: May 9 at 4:05:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
192,403
192,403
84,657
31,479
18,725
Operating Income
-192,403
-192,403
-84,657
-31,479
-18,725
Net Non Operating Interest Income Expense
14,588
14,588
12,756
1,676
-27
Other Income Expense
5
5
3
4
-656
Pretax Income
-177,810
-177,810
-71,898
-29,799
-19,408
Net Income Common Stockholders
-177,810
-177,810
-71,898
-29,799
-19,408
Diluted NI Available to Com Stockholders
-177,810
-177,810
-71,898
-29,799
-19,408
Basic EPS
-3.66
--
-1.99
-0.76
-3.77
Diluted EPS
-3.66
--
-1.99
-0.76
-3.77
Basic Average Shares
48,539.80
--
36,188.25
39,056.65
5,152.75
Diluted Average Shares
48,539.80
--
36,188.25
39,056.65
5,152.75
Total Operating Income as Reported
-192,403
-192,403
-84,657
-31,479
-18,725
Total Expenses
192,403
192,403
84,657
31,479
18,725
Net Income from Continuing & Discontinued Operation
-177,810
-177,810
-71,898
-29,799
-19,408
Normalized Income
-177,810
-177,810
-71,898
-29,799
-18,751
Interest Income
14,588
14,588
12,756
1,676
--
Interest Expense
--
--
--
--
27
Net Interest Income
14,588
14,588
12,756
1,676
-27
EBIT
-192,403
-192,403
-84,657
-31,479
-19,381
EBITDA
-192,360
-192,360
-84,657
-31,479
-19,381
Reconciled Depreciation
43
43
0
--
--
Net Income from Continuing Operation Net Minority Interest
-177,810
-177,810
-71,898
-29,799
-19,408
Total Unusual Items Excluding Goodwill
--
--
--
--
-657
Total Unusual Items
--
--
--
--
-657
Normalized EBITDA
-192,360
-192,360
-84,657
-31,479
-18,724
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/10/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRAX Praxis Precision Medicines, Inc.
38.35
+0.76%
 
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%
 
MIRM Mirum Pharmaceuticals, Inc.
44.27
-2.14%
 
VRDN Viridian Therapeutics, Inc.
12.39
-3.05%
 
KYMR Kymera Therapeutics, Inc.
30.07
-2.27%
 
SYRE Spyre Therapeutics, Inc.
14.10
+9.64%
 
GHRS GH Research PLC
10.38
-3.89%
 
TRVI Trevi Therapeutics, Inc.
6.60
0.00%
 
ENTA Enanta Pharmaceuticals, Inc.
5.27
-0.94%
 
RZLT Rezolute, Inc.
3.7000
-0.54%